StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2023 - 05 - 05
1
2023 - 02 - 13
1
2022 - 09 - 21
1
2022 - 04 - 28
1
2022 - 01 - 04
1
2021 - 09 - 13
1
2021 - 05 - 06
1
2021 - 03 - 11
1
Sector
Health technology
8
Tags
Acquisition
9
Alliances
7
America
31
Antibody
10
Application
12
Approval
22
Asia
8
Biosimilar
21
Biotech-bay
28
Biotech-beach
13
Cancer
91
Cell
7
Clinical-trials-phase-iii
9
Collaboration
10
Companies
11
Conference
35
Deadline
21
Disease
26
Drug
54
Earnings
9
Eb613
11
Europe
15
Events
15
Expected
10
Fda
23
Financial
25
Financial results
13
Gene therapy
7
Global
83
Growing
15
Growth
102
Health
10
Leukemia
10
Liver
7
Lumakras
15
Lung
7
Lung cancer
16
Market
222
N/a
571
Osteoporosis
11
People
26
Pharma
12
Pharmaceuticals
8
Phase 2
15
Phase 3
7
Positive
14
Potential
9
Psoriasis
12
Reach
8
Report
58
Research
45
Results
53
Risk
9
Set
10
Technology
12
Therapeutics
69
Therapy
42
Treatment
46
Trial
13
Update
8
Entities
Abb ltd
5
Abbvie inc.
7
Alphabet inc.
3
Amgen inc.
8
Apple inc.
3
Arrival
6
Asia pacific wire
3
Aslan pharmaceuticals limited
3
Astellas pharma inc
7
Astrazeneca plc
7
Ayala pharmaceuticals, inc.
4
Beigene, ltd.
7
Bio-rad laboratories, inc.
3
Biogen inc.
4
Biolinerx ltd.
5
Biomx inc.
5
Can-fite biopharma ltd
18
Casi pharmaceuticals, inc.
7
Chemomab therapeutics ltd - adr
15
Coherus biosciences, inc.
7
Collplant biotechnologies ltd.
11
Compugen ltd.
25
Enlivex therapeutics ltd.
16
Entera bio ltd.
6
Ericsson
7
Evogene ltd.
20
Galmed pharmaceuticals ltd.
11
Glaxosmithkline plc
5
Gracell biotechnologies inc - adr
6
I-mab
7
Icecure medical ltd
23
Iclick interactive asia group limited
4
Incyte corporation
8
Inmode ltd.
16
Inspira technologies oxy b.h.n. ltd
23
Johnson & johnson
19
Magnite, inc.
4
Mei pharma, inc.
4
Morgan stanley
6
Nabors industries ltd.
5
Nano-x imaging ltd
9
Nikola corporation
4
Novartis ag
4
Orange
5
Pfizer, inc.
4
Polypid ltd.
9
Protalix biotherapeutics, inc.
8
Redhill biopharma ltd.
14
Sanofi
19
Seagen inc.
6
Society pass incorporated.
7
Sofi technologies inc
4
Sol-gel technologies ltd.
5
Takeda pharmaceutical company limited
15
Terex corporation
4
Teva pharmaceutical industries limited
15
Teva pharmaceutical industries ltd
13
Thermo fisher scientific inc
8
Viatris inc.
4
Vision sensing acquisition corp.
5
Symbols
AMGN
8
BGNE
1
BIIB
1
CRSP
1
ENTX
5
Exchanges
Nasdaq
8
Crawled Date
2023 - 05 - 05
1
2023 - 02 - 13
1
2022 - 09 - 21
1
2022 - 04 - 28
1
2022 - 01 - 04
1
2021 - 09 - 13
1
2021 - 05 - 06
1
2021 - 03 - 11
1
Crawled Time
09:00
1
13:00
1
14:00
1
14:15
1
15:00
2
22:04
1
23:00
1
Source
www.biospace.com
8
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Asia
entities :
Amgen inc.
save search
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
Published:
2023-05-05
(Crawled : 09:00)
- biospace.com/
CRSP
|
News
M
|
$56.61
0.36%
270K
|
Health Technology
|
6.19%
|
O:
1.88%
H:
6.97%
C:
3.09%
BIIB
|
$202.05
4.59%
1.1M
|
Health Technology
|
-38.39%
|
O:
0.08%
H:
1.89%
C:
1.35%
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
17.96%
|
O:
0.33%
H:
1.88%
C:
1.66%
west
pharmaceuticals
research
therapy
Entera Bio to Participate in the SVB Securities Global Biopharma Conference
Published:
2023-02-13
(Crawled : 15:00)
- biospace.com/
ENTX
|
$2.22
14K
|
Health Technology
|
143.96%
|
O:
-2.2%
H:
4.49%
C:
1.11%
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
12.8%
|
O:
0.29%
H:
0.26%
C:
0.19%
biopharma
global
conference
Entera Bio Hosting Key Opinion Leader Webinar on the Treatment Landscape for Osteoporosis and EB613’s Potential Impact on Wednesday, September 28th @ 10am ET
Published:
2022-09-21
(Crawled : 13:00)
- biospace.com/
ENTX
|
$2.22
14K
|
Health Technology
|
83.47%
|
O:
0.0%
H:
7.73%
C:
6.61%
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
20.13%
|
O:
0.62%
H:
0.65%
C:
-2.04%
eb613
treatment
impact
potential
osteoporosis
Entera Bio to Report First Quarter 2022 Financial Results on May 12
Published:
2022-04-28
(Crawled : 15:00)
- biospace.com/
ENTX
|
$2.22
14K
|
Health Technology
|
-14.45%
|
O:
-1.73%
H:
2.74%
C:
0.78%
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
9.95%
|
O:
-5.25%
H:
3.05%
C:
1.02%
report
results
Entera Bio Announces Successful EB613 End-of-Phase 2 Meeting with FDA
Published:
2022-01-04
(Crawled : 23:00)
- biospace.com/
ENTX
|
$2.22
14K
|
Health Technology
|
-31.27%
|
O:
8.57%
H:
0.0%
C:
-10.17%
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
20.67%
|
O:
-0.41%
H:
0.0%
C:
0.0%
eb613
fda
phase 2
613
Kyowa Kirin to Present Atopic Dermatitis Clinical Data from KHK4083/AMG 451 Phase 2 Study at The European Academy of Dermatology and Venereology 30th Congress
Published:
2021-09-13
(Crawled : 14:00)
- biospace.com/
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
27.97%
|
O:
1.55%
H:
0.92%
C:
-0.16%
phase 2
europe
dermatitis
atopic dermatitis
Asieris and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of APL-1202 and Tislelizumab
Published:
2021-05-06
(Crawled : 14:15)
- biospace.com/
BGNE
|
$143.42
3.19%
69K
|
Health Technology
|
-54.49%
|
O:
0.14%
H:
3.67%
C:
2.67%
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
9.7%
|
O:
-0.03%
H:
0.88%
C:
0.81%
collaboration
Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021
Published:
2021-03-11
(Crawled : 22:04)
- biospace.com/
ENTX
|
$2.22
14K
|
Health Technology
|
38.75%
|
O:
190.63%
H:
69.25%
C:
-13.12%
AMGN
|
News
|
$273.6
0.02%
370K
|
Health Technology
|
18.95%
|
O:
0.3%
H:
1.43%
C:
0.22%
financial results
results
Gainers vs Losers
57%
43%
Top 10 Gainers
CSSE
4
|
$0.3686
142.02%
76M
|
Consumer Services
CZOO
|
$11.685
134.17%
7.6M
|
BOF
|
$2.05
75.21%
78M
|
AMST
|
$3.14
57.0%
59M
|
Technology Services
LICN
|
$0.7885
40.8%
11M
|
TROO
|
$1.51
38.53%
5.6M
|
Manufacturing
MULN
|
News
|
$3.7
35.53%
6.4M
|
Information
WHLM
|
$6.61
30.12%
400K
|
Commercial Services
RILY
|
$27.91
28.5%
8.9M
|
Finance
RBBN
4
|
$3.25
26.46%
1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.